Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-09-13 4:47 pm Purchase | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Daniel C. | 9,872,901 14.600% | 9,872,901 (New Position) | View |
| 2022-06-17 5:00 pm Unchanged | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 14,868,329 22.300% | 0 (Unchanged) | View |
| 2022-06-03 3:59 pm Sale | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 14,868,329 22.300% | -13,051,676 (-46.75%) | View |
| 2021-11-02 4:02 pm Sale | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 27,920,005 48.190% | -869,188 (-3.02%) | View |
| 2021-06-04 10:17 am Purchase | 13D | NRX Pharmaceuticals Inc. NRXP | BRAC Lending Group LLC | 1,161,675 2.440% | 1,161,675 (New Position) | View |
| 2021-06-03 5:30 pm Purchase | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 28,789,193 60.660% | 28,789,193 (New Position) | View |
| 2021-05-26 5:02 pm Purchase | 13D | NRX Pharmaceuticals Inc. NRXP | Big Rock Partners Sponsor LLC | 815,565 1.510% | 815,565 (New Position) | View |
| 2021-02-16 08:49 am Sale | 13G | NRX Pharmaceuticals Inc. NRXP | OXFORD ASSET MANAGEMENT LLP | 0 0.000% | -431,602 (Position Closed) | View |
| 2021-02-12 6:33 pm Sale | 13G | NRX Pharmaceuticals Inc. NRXP | K2 PRINCIPAL FUND L.P. | 0 0.000% | -433,091 (Position Closed) | View |
| 2021-02-11 6:02 pm Sale | 13G | NRX Pharmaceuticals Inc. NRXP | Magnetar Financial LLC | 0 0.000% | -465,000 (Position Closed) | View |
| 2020-04-10 3:44 pm Sale | 13G | NRX Pharmaceuticals Inc. NRXP | Polar Asset Management Partners Inc. | 0 0.000% | -517,500 (Position Closed) | View |
| 2020-03-10 5:14 pm Unchanged | 13G | NRX Pharmaceuticals Inc. NRXP | Polar Asset Management Partners Inc. | 517,500 10.040% | 0 (Unchanged) | View |
| 2020-02-13 5:00 pm Purchase | 13G | NRX Pharmaceuticals Inc. NRXP | K2 PRINCIPAL FUND L.P. | 433,091 7.140% | 433,091 (New Position) | View |
| 2020-02-13 10:23 am Purchase | 13G | NRX Pharmaceuticals Inc. NRXP | OXFORD ASSET MANAGEMENT LLP | 431,602 7.110% | 431,602 (New Position) | View |
| 2020-02-12 6:04 pm Purchase | 13G | NRX Pharmaceuticals Inc. NRXP | Magnetar Financial LLC | 465,000 7.660% | 465,000 (New Position) | View |
| 2020-02-10 11:40 am Sale | 13G | NRX Pharmaceuticals Inc. NRXP | Polar Asset Management Partners Inc. | 517,500 8.530% | -300,000 (-36.70%) | View |